Medicenna Therapeutics Corp (MDNA) - Total Liabilities

Latest as of December 2025: CA$6.85 Million CAD ≈ $4.96 Million USD

Based on the latest financial reports, Medicenna Therapeutics Corp (MDNA) has total liabilities worth CA$6.85 Million CAD (≈ $4.96 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Medicenna Therapeutics Corp liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Medicenna Therapeutics Corp - Total Liabilities Trend (2014–2025)

This chart illustrates how Medicenna Therapeutics Corp's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Medicenna Therapeutics Corp (MDNA) total assets.

Medicenna Therapeutics Corp Competitors by Total Liabilities

The table below lists competitors of Medicenna Therapeutics Corp ranked by their total liabilities.

Company	Country	Total Liabilities
Morphic Ethical Equities Fund Ltd AU:MEC	Australia	AU$2.05 Million
Vmoto Ltd AU:VMT	Australia	AU$34.15 Million
Champion Pacific Indonesia Tbk JK:IGAR	Indonesia	Rp133.55 Billion
Keller Group PLC LSE:KLR	UK	GBX1.21 Billion
Boundless Bio, Inc. Common Stock NASDAQ:BOLD	USA	$58.55 Million
Milae Bioresources Co. Ltd KQ:218150	Korea	₩22.10 Billion
LMS Co. Ltd KQ:073110	Korea	₩93.49 Billion
Pamapol S.A. WAR:PMP	Poland	zł500.62 Million

Liability Composition Analysis (2014–2025)

This chart breaks down Medicenna Therapeutics Corp's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See MDNA net asset quality index to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.68	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	2.20	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.10	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.52	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Medicenna Therapeutics Corp's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Medicenna Therapeutics Corp (2014–2025)

The table below shows the annual total liabilities of Medicenna Therapeutics Corp from 2014 to 2025.

Year	Total Liabilities	Change
2025-03-31	CA$9.29 Million ≈ $6.72 Million	-33.39%
2024-03-31	CA$13.94 Million ≈ $10.09 Million	+100.33%
2023-03-31	CA$6.96 Million ≈ $5.03 Million	+165.55%
2022-03-31	CA$2.62 Million ≈ $1.90 Million	-36.18%
2021-03-31	CA$4.11 Million ≈ $2.97 Million	+122.34%
2020-03-31	CA$1.85 Million ≈ $1.34 Million	-28.15%
2019-03-31	CA$2.57 Million ≈ $1.86 Million	+16.18%
2018-03-31	CA$2.21 Million ≈ $1.60 Million	-71.73%
2017-03-31	CA$7.83 Million ≈ $5.66 Million	+122.97%
2016-03-31	CA$3.51 Million ≈ $2.54 Million	+1102.65%
2015-03-31	CA$291.87K ≈ $211.13K	-64.83%
2014-03-31	CA$829.89K ≈ $600.33K	--

About Medicenna Therapeutics Corp

TO:MDNA Canada Biotechnology

Market Cap

$25.65 Million

CA$35.45 Million CAD

Market Cap Rank

#24390 Global

#920 in Canada

Share Price

CA$0.43

Change (1 day)

+4.94%

52-Week Range

CA$0.35 - CA$1.64

All Time High

CA$7.00